Clinical Outcomes in High Risk WHO Grade II Glioma Patients Treated with Upfront TMZ-Based Chemoradiotherapy

Published in: International Journal of Radiation Oncology*Biology*Physics

Volume 114, Issue 3, pp. e81-e82

DOI: 10.1016/j.ijrobp.2022.07.852